Orexo Continues to Strengthen ZUBSOLV’s Patent Portfolio with Two New Patents | New
UPPSALA, Sweden, June 2, 2021 / PRNewswire / – Orexo AB (launched), (STO: ORX) (OTCQX: ORXOY) proclaims at the moment that the USA Patent and Trademark Workplace (USPTO) has granted two extra patents referring to ZUBSOLV®, the buprenorphine and naloxone (CII) sublingual pill of Orexo for the remedy of opioid use problems.
The brand new patents, U.S. Patent Nos. 11,020,387 and 11,020,388, expire in September 2032. Orexo will now have 9 patents listed within the Orange E book referring to ZUBSOLV®.
Nikolaj Sørensen, President and CEO, mentioned: “I’m delighted that the USPTO continues to acknowledge the distinctiveness of the expertise behind ZUBSOLV® by granting two new patents which additional strengthen the patent portfolio for ZUBSOLV®. Full patent safety is a vital cornerstone to take care of ZUBSOLV’s robust revenue contribution and guarantee its development over time – one among our key goals for the general long-term development of the corporate.”
For extra data, please contact: Orexo AB (publ.)
Nikolaj Sørensen, President and CEO
Telephone: +46 (0) 18 780 88 00
Lena Wange, Director of Public Relations and Communications
Telephone: +46 (0) 18 780 88 0
E-mail: [email protected]
E-mail: [email protected]
Orexo develops improved prescribed drugs and digital therapies that tackle unmet wants within the rising house of substance use problems and psychological well being. The merchandise are marketed by Orexo in the USA or via companions all over the world. The first market at the moment is the US buprenorphine / naloxone market, the place Orexo markets its flagship product, ZUBSOLV®, for the remedy of opioid use problems. Orexo’s complete turnover in 2020 quantities to 664 million Swedish kronor and the variety of workers was 138. Orexo is listed on the Nasdaq Stockholm Mid Cap (ORX) and is accessible as ADR on OTCQX (ORXOY) in the USA. The corporate is headquartered in Uppsala, Sweden, the place analysis and improvement actions are carried out.
For extra data on Orexo, please go to www.orexo.com. You may also comply with Orexo on Twitter, @orexoabpubl, LinkedIn and YouTube.
The knowledge has been submitted for publication to 8:00 am CET, at June 2, 2021.
This data was dropped at you by Cision http://information.cision.com
The next recordsdata can be found for obtain:
Present authentic content material:http://www.prnewswire.com/news-releases/orexo-continues-to-strengthen-zubsolvs-patent-portfolio-with-two-new-patents-301303614.html